Page last updated: 2024-08-23

raloxifene hydrochloride and Hemorrhage, Uterine

raloxifene hydrochloride has been researched along with Hemorrhage, Uterine in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (11.11)	18.2507
2000's	6 (66.67)	29.6817
2010's	2 (22.22)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brito, LG; Candido Dos Reis, FJ; Ferriani, RA; Martins, WP; Moroni, RM; Nastri, CO; Vieira, CS	1
Alam, J; Bhattoa, HP; Cox, DA; Dowsett, SA; Goldstein, SR; Muram, D; Neven, P; Sipos, A	1
Benedetti-Panici, P; Cano, A; de Villiers, T; Hillard, T; Lunde, T; Marinescu, B; Neven, P; Nickelsen, T; Peer, E; Quail, D; Tiitinen, A	1
Shintani, M	1
Bontis, J; Dinas, K; Tsalikis, T; Zafrakas, M; Zepiridis, L	1
Davies, GC; Huster, WJ; Lakshmanan, M; Lu, Y; Plouffe, L	1
Body, JJ; Sternon, J	1
Eriksen, EF	1
Grow, DR; Reece, MT	1

Reviews

4 review(s) available for raloxifene hydrochloride and Hemorrhage, Uterine

Article	Year
Add-back therapy with GnRH analogues for uterine fibroids. The Cochrane database of systematic reviews, 2015, Mar-20, Issue:3 Topics: Antineoplastic Agents, Hormonal; Bone Density; Bone Density Conservation Agents; Drug Therapy, Combination; Estriol; Female; Gonadotropin-Releasing Hormone; Humans; Isoflavones; Leiomyoma; Medroxyprogesterone; Norpregnenes; Quality of Life; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Uterine Hemorrhage; Uterine Neoplasms	2015
[Which is the better choice, estrogen or SERMs in postmenopausal women?]. Clinical calcium, 2004, Volume: 14, Issue:10 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Female; Hip Fractures; Hot Flashes; Humans; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk; Selective Estrogen Receptor Modulators; Spinal Fractures; Uterine Hemorrhage	2004
[Raloxifene]. Ugeskrift for laeger, 2000, Jul-31, Volume: 162, Issue:31 Topics: Breast Neoplasms; Endometrium; Estrogen Antagonists; Female; Humans; Menopause; Middle Aged; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Uterine Hemorrhage	2000
The role of selective oestrogen receptor modulators in the treatment of endometrial bleeding in women using long-acting progestin contraception. Human reproduction (Oxford, England), 2000, Volume: 15 Suppl 3 Topics: Contraceptive Agents, Female; Estrogen Antagonists; Female; Humans; Neovascularization, Physiologic; Progestins; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Uterine Hemorrhage	2000

Trials

3 trial(s) available for raloxifene hydrochloride and Hemorrhage, Uterine

Article	Year
Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass. Menopause (New York, N.Y.), 2012, Volume: 19, Issue:1 Topics: Aged; Aged, 80 and over; Endometrial Neoplasms; Endometrium; Female; Genital Diseases, Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Piperidines; Placebos; Polyps; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thiophenes; Uterine Hemorrhage; Vaginitis; Vulvitis	2012
A multicentre randomised trial to compare uterine safety of raloxifene with a continuous combined hormone replacement therapy containing oestradiol and norethisterone acetate. BJOG : an international journal of obstetrics and gynaecology, 2003, Volume: 110, Issue:2 Topics: Aged; Double-Blind Method; Estradiol; Estrogen Antagonists; Female; Humans; Middle Aged; Norethindrone; Osteoporosis, Postmenopausal; Progesterone Congeners; Prospective Studies; Raloxifene Hydrochloride; Single-Blind Method; Time Factors; Treatment Outcome; Uterine Diseases; Uterine Hemorrhage	2003
Adverse events reported by postmenopausal women in controlled trials with raloxifene. Obstetrics and gynecology, 1999, Volume: 93, Issue:4 Topics: Adult; Aged; Breast Diseases; Estrogen Antagonists; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Incidence; Middle Aged; Pain; Piperidines; Postmenopause; Raloxifene Hydrochloride; Uterine Hemorrhage	1999

Other Studies

2 other study(ies) available for raloxifene hydrochloride and Hemorrhage, Uterine

Article	Year
Endometrial lesions causing uterine bleeding in postmenopausal women receiving raloxifene. Maturitas, 2005, Jun-16, Volume: 51, Issue:2 Topics: Administration, Oral; Adult; Endometrial Hyperplasia; Endometrium; Female; Humans; Osteoporosis, Postmenopausal; Polyps; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Ultrasonography; Uterine Diseases; Uterine Hemorrhage	2005
[Raloxifene (Celvista, Evista)]. Revue medicale de Bruxelles, 2000, Volume: 21, Issue:1 Topics: Arteriosclerosis; Bone and Bones; Breast Neoplasms; Controlled Clinical Trials as Topic; Endometrium; Female; Fractures, Bone; Heart Diseases; Hip Fractures; Humans; Middle Aged; Osteoporosis, Postmenopausal; Placebos; Prospective Studies; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Spinal Fractures; Thromboembolism; Uterine Hemorrhage	2000

Article

Year

Endometrial lesions causing uterine bleeding in postmenopausal women receiving raloxifene.

Maturitas, 2005, Jun-16, Volume: 51, Issue:2

Topics: Administration, Oral; Adult; Endometrial Hyperplasia; Endometrium; Female; Humans; Osteoporosis, Postmenopausal; Polyps; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Ultrasonography; Uterine Diseases; Uterine Hemorrhage

2005

[Raloxifene (Celvista, Evista)].

Revue medicale de Bruxelles, 2000, Volume: 21, Issue:1

Topics: Arteriosclerosis; Bone and Bones; Breast Neoplasms; Controlled Clinical Trials as Topic; Endometrium; Female; Fractures, Bone; Heart Diseases; Hip Fractures; Humans; Middle Aged; Osteoporosis, Postmenopausal; Placebos; Prospective Studies; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Spinal Fractures; Thromboembolism; Uterine Hemorrhage

2000